Close
  Indian J Med Microbiol
 

Figure 2: Osmotic fragility curves (a) treatment Group D with MCF of 0.355%; and (b) treatment Group E with MCF of 0.355%. There is no statistically significant difference between the MCF in 10 and 20 mg/mL of the aqueous extract when compared with control and 10 mg/mL of KSCN. PBS - Phosphate-buffered saline, MCF - Mean corpuscular fragility, KSCN - potassium thiocyanate

Figure 2: Osmotic fragility curves (a) treatment Group D with MCF of 0.355%; and (b) treatment Group E with MCF of 0.355%. There is no statistically significant difference between the MCF in 10 and 20 mg/mL of the aqueous extract when compared with control and 10 mg/mL of KSCN. PBS - Phosphate-buffered saline, MCF - Mean corpuscular fragility, KSCN - potassium thiocyanate